USD 0.05
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 798.44 Thousand USD | 193.75% |
2022 | 271.8 Thousand USD | 0.0% |
2021 | 271.8 Thousand USD | -56.73% |
2020 | 628.23 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2015 | 1.01 Million USD | 0.0% |
2014 | 1.01 Million USD | 99900.0% |
2013 | 1016.09 USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 798.44 Thousand USD | 0.0% |
2024 Q1 | 798.44 Thousand USD | 0.0% |
2023 Q4 | 798.44 Thousand USD | 0.0% |
2023 Q3 | 798.44 Thousand USD | 0.0% |
2023 Q2 | 798.44 Thousand USD | 0.0% |
2023 Q1 | 798.44 Thousand USD | 193.75% |
2023 FY | 798.44 Thousand USD | 193.75% |
2022 Q3 | 196.05 Million USD | 72029.3% |
2022 FY | 271.8 Thousand USD | 0.0% |
2022 Q4 | 271.8 Thousand USD | -99.86% |
2022 Q2 | 271.8 Thousand USD | 0.0% |
2022 Q1 | 271.8 Thousand USD | 0.0% |
2021 FY | 271.8 Thousand USD | -56.73% |
2021 Q3 | 981.57 Thousand USD | 12.75% |
2021 Q2 | 870.57 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | 628.23 Thousand USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 Q1 | 1.01 Million USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2015 FY | 1.01 Million USD | 0.0% |
2014 FY | 1.01 Million USD | 99900.0% |
2013 FY | 1016.09 USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Bio Medica Corporation | 6000.00 USD | -13207.35% |
Arrayit Corporation | - USD | -Infinity% |
Atlantic International Corp. | 1.29 Million USD | 38.464% |
Biocept, Inc. | 10.37 Million USD | 92.304% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 51.3 Million USD | 98.444% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 98.696% |
HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -46.148% |
iMD Companies, Inc. | 1.1 Million USD | 27.656% |
IDenta Corp. | 428.17 Thousand USD | -86.475% |
Interpace Biosciences, Inc. | 4.24 Million USD | 81.182% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | - USD | -Infinity% |
Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 278 Thousand USD | -187.209% |
NovelStem International Corp. | 3.32 Million USD | 75.984% |
Optigenex Inc. | 4.42 Million USD | 81.965% |
PharmChem, Inc. | - USD | -Infinity% |
Proteome Sciences plc | 1.63 Million USD | 51.046% |
Response Genetics, Inc | 4.91 Million USD | 83.765% |
Rennova Health, Inc. | 359.19 Thousand USD | -122.287% |
RushNet, Inc. | 4.25 Million USD | 81.224% |
ScreenPro Security Inc. | 249.05 Thousand USD | -220.595% |
StageZero Life Sciences Ltd. | 576.38 Thousand USD | -38.526% |
Todos Medical Ltd. | 33 Million USD | 97.581% |